High <i>p62</i> and <i>ALDH1A3</i> Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer.

Cancer Diagn Progn · 2025 · PMC12577621 · PMID 41179310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Moreover, patients with p62 high ALDH1A3 high luminal B breast cancer treated with tamoxifen showed a trend towards a poor prognosis, but those treated with aromatase inhibitors showed a significantly poor prognosis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

High &lt;i&gt;p62&lt;/i&gt; and &lt;i&gt;ALDH1A3&lt;/i&gt; Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer.

The sentences

High <i>p62</i> and <i>ALDH1A3</i> Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer.